Gotham__Org Gotham White.png
FACT-BP

Functional Assessment of Cancer Therapy - Bone Pain

For patients with Bone Pain

 

Overview

Below are the details for the FACT-BP measure:

MEASURE NAME:

Functional Assessment of Cancer Therapy - Bone Pain (FACT-BP)

VERSION:

4

NUMBER OF ITEMS:

16

PATIENT POPULATION:

Cancer patients 18 years and older experiencing bone pain

RECALL PERIOD:

Past 7 days

RESPONSE SCALE:

5 point Likert-type scale

DATA COLLECTION:

Paper and electronic

ADMINISTRATION:

Self-administration and interview when applicable

SUBSCALE DOMAINS:

None

TIME FOR COMPLETION:

Less than 5 minutes

SCORING:

Manual scoring template, some items are reverse scored. Total scores possible

RELATED MEASURES:

Language Availability

Available translations of the FACT-BP can be obtained by registering for permission. Users are not permitted to translate the FACT-BP without permission from FACIT.org. Permission from FACIT.org to translate the FACT-BP may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system.

Please contact us for more information.

 
 

Licensing

Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained.

Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use.

To license an available version of this measure for commercial or non-commercial use, please complete our registration form. All of the information provided in the form will be kept strictly confidential. For questions, please contact us.

 

Selected References

Broom, R., Du, H., Clemons, M., Eton, D., Dranitsaris, G., Simmons, C., Ooi, W., & Cella, D.  Switching breast cancer patients with progressive bone metastases to third generation bisphosphonates: Measuring the impact on bone pain and related issues using the Functional Assessment of Cancer Therapy – Bone Pain (FACT-BP). Journal of Pain and Symptom Management 2009; 38(2): 244-257. doi: 10.1016/j.jpainsymman.2008.08.005.


Fallowfield, L., Stebbing, J., Braybrooke, J., Langridge, C., & Jenkins, V.  The preferences and experiences of different bisphosphonate treatments in women with breast cancer. Psycho-Oncology 2011; 20: 755–761. doi: 10.1002/pon.1781.


Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320.


Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232.


Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85.


Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191.

 

Related Measures

FACIT-BTCSQ

Functional Assessment of Chronic Illness Therapy - Bone Treatment Convenience and Satisfaction Questionnaire

FACT-BMT

Functional Assessment of Cancer Therapy - Bone Marrow Transplantation

FACT-G

Functional Assessment of Cancer Therapy – General

Gotham__Group-Gotham-White_SFW.png
Lauren Lent, DHA, MS
President, FACITtrans, LLC
Executive Director, FACIT.org
About Us
© 2020 FACIT.org 
Benjamin Arnold, MA
Executive Director, FACITtrans, LLC
Jason Bredle, MFA
Director, FACIT.org